A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies (Q34262817)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies |
scientific article |
Statements
1 reference
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies (English)
1 reference
Michael J Pishvaian
1 reference
John L Marshall
1 reference
Andrew J Wagner
1 reference
Jimmy J Hwang
1 reference
Shakun Malik
1 reference
Ion Cotarla
1 reference
John F Deeken
1 reference
A Ruth He
1 reference
Hirut Daniel
1 reference
Abdel-Baset Halim
1 reference
Hamim Zahir
1 reference
Catherine Copigneaux
1 reference
Kejian Liu
1 reference
Robert A Beckman
1 reference
George D Demetri
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference